Advancement in New Drug Discovery for Treatment of Hepatitis
The current existing treatments eliminates the virus in only a little more than half of all patients. Those drugs may also have unwanted side effects which makes it difficult for patients to take them. In recent years, tremendous research advances are transforming on treatment of Hepatitis. This progress has occurred in just last three years with new and effective therapies transforming the trajectory of the disease for many patients. The scientific advances that are made by biopharmaceutical researchers have already begun to have a tangible impact on thousands of patients. In all these areas, rapid progress is being made and more new medicines are on the way. The Food and Drug Administration has approved a new drug named Harvoni, which combines sofosbuvir and ledipasvir which cures Hepatitis C virus in just eight weeks.
Related Conference of Advancement in New Drug Discovery for Treatment of Hepatitis
16th International Conference on Chronic Obstructive Pulmonary Disease
5th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Advancement in New Drug Discovery for Treatment of Hepatitis Conference Speakers
Recommended Sessions
- Advancement in New Drug Discovery for Treatment of Hepatitis
- Critical Care and Hepatology Nursing
- Epidemiology of Hepatitis
- Hepatitis Care
- Hepatocellular Carcinoma
- Intestinal Rehabilitation
- Liver Cancer
- Liver Diseases Diagnosis
- Liver Fibrosis
- Liver Transplantation and Surgery
- Molecular Biology of Hepatitis A, B, C, D and E Viruses
- Pancreatic Diseases
- Pathophysiology of Hepatitis
- Pediatric Gastroenterology, Hepatology and Nutrition
- Pregnancy and Liver Diseases
- Recent Advances in the Viral Hepatitis C Treatment
- Types of Hepatitis
- Viral Hepatitis Management
Related Journals
Are you interested in
- Asthma - Pulmonary Meet 2024 (France)
- Asthma and Allergy - COPD CONGRESS 2024 (UK)
- Asthma and COPD - COPD_2024 (France)
- Asthma Management - COPD SUMMIT 2025 (Italy)
- Asthma-COPD Overlap - COPD SUMMIT 2025 (Italy)
- Cardio Pulmonary Disorders - COPD CONGRESS 2024 (UK)
- Chronic bronchitis - COPD CONGRESS 2024 (UK)
- Chronic Bronchitis - Pulmonary Meet 2024 (France)
- Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- Chronic Obstructive Pulmonary Disease - COPD_2024 (France)
- Chronic Obstructive Pulmonary Disease - COPD SUMMIT 2025 (Italy)
- Clinical Immunology & Genetics - COPD SUMMIT 2025 (Italy)
- Clinical Trials - COPD SUMMIT 2025 (Italy)
- Co-Morbidities of COPD - COPD_2024 (France)
- COPD - Pulmonary Meet 2024 (France)
- COPD and Air Pollution - COPD CONGRESS 2024 (UK)
- COPD and Cardiovascular Diseases - COPD_2024 (France)
- COPD Complications - COPD_2024 (France)
- COPD Exacerbations - COPD_2024 (France)
- COPD Pathogenesis - COPD SUMMIT 2025 (Italy)
- COPD Pathogenesis - COPD_2024 (France)
- COPD Pathogenesis - COPD CONGRESS 2024 (UK)
- COPD Preventative Measures - COPD SUMMIT 2025 (Italy)
- COPD Therapeutics - COPD_2024 (France)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- COPD: Sign and Symptoms - COPD_2024 (France)
- Cystic Fibrosis - Pulmonary Meet 2024 (France)
- Depression and Anxiety in COPD - COPD SUMMIT 2025 (Italy)
- Depression and Anxiety in COPD - COPD CONGRESS 2024 (UK)
- Depression and anxiety in COPD - COPD_2024 (France)
- Diagnosis and Treatment of COPD - COPD CONGRESS 2024 (UK)
- Diagnosis and Treatment of COPD - COPD SUMMIT 2025 (Italy)
- Drug Discovery of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD_2024 (France)
- Drug Discovery of COPD - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD CONGRESS 2024 (UK)
- Effect of COVID-19 on Lungs - COPD SUMMIT 2025 (Italy)
- Emphysema - Pulmonary Meet 2024 (France)
- Emphysema - COPD CONGRESS 2024 (UK)
- Epidemiology - COPD SUMMIT 2025 (Italy)
- Epidemiology of COPD - COPD_2024 (France)
- Experimental Models - COPD SUMMIT 2025 (Italy)
- Genetic risk factor of COPD - COPD_2024 (France)
- Infectious Respiratory Diseases - Pulmonary Meet 2024 (France)
- Interstitial lung disease - Pulmonary Meet 2024 (France)
- Lung and COVID-19 - COPD SUMMIT 2025 (Italy)
- Lung cancer - COPD_2024 (France)
- Lung Cancer - Pulmonary Meet 2024 (France)
- Lung cancer - COPD CONGRESS 2024 (UK)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS 2024 (UK)
- Lung problems - Pulmonary Meet 2024 (France)
- Lung Transplantation - COPD SUMMIT 2025 (Italy)
- Lung transplantation - Pulmonary Meet 2024 (France)
- Lung Transplantation - COPD CONGRESS 2024 (UK)
- Pathophysiology & Pharmacology - COPD SUMMIT 2025 (Italy)
- Pathophysiology of COPD - COPD_2024 (France)
- Pediatric Neonatal Care in COPD - COPD CONGRESS 2024 (UK)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2024 (France)
- Pediatric Pulmonology & Critical care - COPD CONGRESS 2024 (UK)
- Pharmacological and Non-Pharmacological Treatments - COPD SUMMIT 2025 (Italy)
- Pleural Diseases - Pulmonary Meet 2024 (France)
- Prevention and Control of Respiratory disease - Pulmonary Meet 2024 (France)
- Prevention of COPD - COPD CONGRESS 2024 (UK)
- Pulmonary diseases - COPD CONGRESS 2024 (UK)
- Pulmonary diseases-treatment and therapies - COPD_2024 (France)
- Pulmonary Hypertension - COPD_2024 (France)
- Pulmonary Hypertension - Pulmonary Meet 2024 (France)
- Pulmonary Rehabilitation - Pulmonary Meet 2024 (France)
- Pulmonary Rehabilitation - COPD CONGRESS 2024 (UK)
- Pulmonary Rehabilitation - COPD SUMMIT 2025 (Italy)
- Pulmonary vascular disease - Pulmonary Meet 2024 (France)
- Pulmonology - Pulmonary Meet 2024 (France)
- Respiratory and sleep Medicine - COPD CONGRESS 2024 (UK)
- Respiratory Disorders - Pulmonary Meet 2024 (France)
- Respiratory Failure - COPD SUMMIT 2025 (Italy)
- Respiratory Failure and COPD Complications: - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - Pulmonary Meet 2024 (France)
- Self-Management and Prevention of COPD - COPD_2024 (France)
- Self-Management and Prevention of COPD - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD SUMMIT 2025 (Italy)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2024 (France)
- Spirometry - COPD SUMMIT 2025 (Italy)
- Spirometry - COPD CONGRESS 2024 (UK)
- Stages & Severity on Lung Diseases - COPD CONGRESS 2024 (UK)
- Tobacco control - COPD CONGRESS 2024 (UK)
- Tuberculosis - Pulmonary Meet 2024 (France)
- Types of COPD - COPD_2024 (France)
- Types of COPD - COPD CONGRESS 2024 (UK)